TCL Archive EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure. March 2, 2007
TCL Archive Sponsors Wanted: FDA Offers Incentives For Pediatric Oncology Drug Development. March 10, 2000